Vaxxinity Inc. Class AVAXX

13F holders, Q2 2024 (June 30)
8holders −50
0new positions
51sold out
$0.25avg. 13F price*

At the end of Q2 2024, 8 institutions reported holding Vaxxinity Inc. Class A (VAXX) in their 13F filings, down 50 from Q1 2024. 0 opened new positions and 51 sold out. The largest holders were Spire Wealth Management ($40K), XTX Topco Ltd ($17K) and Clarius Group, LLC ($5K).

Company
Vaxxinity Inc. Class A
CUSIP
92244V104
Latest filing quarter
Q1 2026

History

Number of 13F holders

0204060 Q1 2024: 58Q1 2024Q2 2024: 8Q2 2024Q1 2025: 1Q1 2025Q3 2025: 1Q3 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions0$0
Exits51$8.7M

All 13F filers, Q1 2024 → Q2 2024: 201,055 shares bought and 12,095,094 shares sold, net −11,894,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Spire Wealth Management 0.00% Add +1703.7% 161,776 $40K
XTX Topco Ltd 0.00% Add +255.8% 67,106 $17K
Clarius Group, LLC 0.00% No change 20,000 $5K
Glenmede Trust Co. NA 0.00% No change 19,158 $5K
Osaic Holdings, Inc. 0.00% Reduce -68.8% 2,386 $596
Federation des caisses Desjardins du Quebec 0.00% No change 825 $206
Robinswood Financial LLC 0.00% No change 55 $13
Barclays PLC 0.00% Reduce -100.0% 2 $0

"% of holder's portfolio" is VAXX's weight in each manager's 13F, not the share of Vaxxinity Inc. Class A the manager owns.